NOVEL THERAPEUTICS TARGET INNATE IMMUNE RESPONSES FOR TREATING MULTIPLE ORGAN FAILURE IN SEVERE POLYTRAUMA DURING PROLONGED CASUALTY CARE

Metis Foundation, San Antonio TX

Investigators